Milestone Scientific (MLSS) Cash from Financing Activities (2011 - 2026)
Milestone Scientific (MLSS) posted Cash from Financing Activities of -$3428.0 for Q1 2026, little changed sequentially from -$3414.0 in Q4 2025, and down 50.48% YoY from -$6922.9 in Q1 2025.
Milestone Scientific (MLSS) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Milestone Scientific has reported Cash from Financing Activities for 15 years, with the latest figure at -$3428.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 50.48% year-over-year to -$3428.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $785185.0 (up 8002.43% YoY) and the FY2025 annual result came in at $786335.0, up 236.37% from the prior year.
- Cash from Financing Activities was little changed at -$3428.0 in Q1 2026 per MLSS's latest filing, from -$3414.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $2.6 million in Q4 2023 and troughed at -$4556.0 in Q3 2025.
- A 5-year average of $209933.5 and a median of -$2171.0 in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities plunged 102.87% in 2022, then surged 124843.49% in 2023.
- Over 5 years, Cash from Financing Activities stood at -$2058.0 in 2022, then soared by 124843.49% to $2.6 million in 2023, then plunged by 100.1% to -$2523.0 in 2024, then tumbled by 35.32% to -$3414.0 in 2025, then fell by 0.41% to -$3428.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$3428.0, -$3414.0, and -$4556.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Milestone Scientific | 41.18 Mn | 38.57 Mn | 1.56 Mn | -3,428.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,428.00 |
| Mar 31, 2026 | -3,428.00 |
| Dec 31, 2025 | -3,414.00 |
| Dec 31, 2025 | -3,414.00 |
| Sep 30, 2025 | -4,556.00 |
| Sep 30, 2025 | -4,556.00 |
| Jun 30, 2025 | 796,583.00 |
| Jun 30, 2025 | 796,583.00 |
| Mar 31, 2025 | -2,278.00 |
| Mar 31, 2025 | -2,278.00 |
| Dec 31, 2024 | -2,523.00 |
| Dec 31, 2024 | -2,523.00 |
| Sep 30, 2024 | -2,595.00 |
| Sep 30, 2024 | -2,595.00 |
| Jun 30, 2024 | -2,540.00 |
| Jun 30, 2024 | -2,540.00 |
| Mar 31, 2024 | 241,429.00 |
| Mar 31, 2024 | 241,429.00 |
| Dec 31, 2023 | 2.57 Mn |
| Dec 31, 2023 | 2.57 Mn |